Skip to content

Clinical trials

Lung Neoplasms trials in Serbia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Country / region: Serbia Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20061
20082
20091
20111
20161
20191
20222
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting4
Terminated3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen1
AstraZeneca1
CSL Behring1
Gustave Roussy, Cancer Campus, Grand Paris1
Mirati Therapeutics Inc.1
NovaRx Corporation1
Pharmacyclics LLC.1
Prestige Biopharma Limited1
Revolution Medicines, Inc.1
Samsung Bioepis Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms13
Carcinoma, Non-Small-Cell Lung9
Neoplasms3
Neoplasm Metastasis2
Anemia1
Appendiceal Neoplasms1
Bronchial Neoplasms1
Cachexia1
Carcinoma, Pancreatic Ductal1
Carcinoma, Small Cell1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.